Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients With Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-016-0474-0

Related search